2026. Trastuzumab in the Second-Line Treatment of HER2-Positive Metastatic Gastric Cancer. Experience of the Moscow Oncology Service. Voprosy onkologii. 72, 2 (May 2026), OF-2514. DOI:https://doi.org/10.37469/0507-3758-2026-72-2-OF-2514.